• DeutschDeutsch
  • EnglishEnglish
    • ABOUT
    • ONCOLOGY
    • PRODUCT
    • NEWS
    • INQUIRIES
    • VISIT US

Warning: Use of undefined constant simple_breadcrumb - assumed 'simple_breadcrumb' (this will throw an Error in a future version of PHP) in /homepages/43/d33652654/htdocs/wordpress/wp-content/themes/oncoscience2016/archive.php on line 3

ARCHIVES

  • June 2022
  • May 2022
  • November 2020
  • March 2019
  • October 2018
  • November 2017
  • August 2017
  • April 2016
  • July 2015
  • July 2010
  • October 2009
  • October 2008
  • April 2008
  • October 2007
  • September 2007
  • June 2007
  • September 2005
  • March 2005
  • January 2005
  • October 2004
  • August 2004
  • June 2004
  • March 2004
  • November 2003

SEARCH

  • YM BioSciences partner Oncoscience AG reports update of pediatric brain cancer data

    Oncoscience | September 30th, 2005

    Nimotuzumab (Theraloc;TheraCIM h-R3) Phase II results awarded best poster prize at the 37th congress of the Internationa...

  • YM BioSciences and Oncoscience Report Response Rate of 35.3% in Pediatric Glioma

    Oncoscience | March 1st, 2005

    TheraCIM h-R3 (nimotuzumab) Phase II Results Presented at European High Grade Glioma Conference MISSISSAUGA, ON, Feb. 2...

  • YM Biosciences and Oncoscience AG achieve clinical milestone

    Oncoscience | January 10th, 2005

    Results Permit Pediatric Brain Cancer Trial to be Converted into Pivotal Randomized First-Line Therapy Trial MISSISSAUG...

    • LEGAL NOTICE

©Copyright of Oncoscience GmbH 2023

Diese Website benutzt Cookies. Wenn du die Website weiter nutzt, gehen wir von deinem Einverständnis aus.OKDatenschutzerklärung